Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.9800
+0.0300 (3.16%)
Apr 25, 2025, 12:46 PM EDT - Market open
Milestone Scientific Market Cap
Milestone Scientific has a market cap or net worth of $76.81 million as of April 25, 2025. Its market cap has increased by 83.32% in one year.
Market Cap
76.81M
Enterprise Value
71.55M
1-Year Change
83.32%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since December 1, 1998, Milestone Scientific's market cap has increased from $9.90M to $76.81M, an increase of 675.88%. That is a compound annual growth rate of 8.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2025 | 74.50M | -0.40% |
Dec 31, 2024 | 74.80M | 52.65% |
Dec 29, 2023 | 49.00M | 46.27% |
Dec 30, 2022 | 33.50M | -76.04% |
Dec 31, 2021 | 139.80M | 3.56% |
Dec 31, 2020 | 135.00M | 98.82% |
Dec 31, 2019 | 67.90M | 506.25% |
Dec 31, 2018 | 11.20M | -71.28% |
Dec 29, 2017 | 39.00M | -0.76% |
Dec 30, 2016 | 39.30M | -22.18% |
Dec 31, 2015 | 50.50M | 3.27% |
Dec 31, 2014 | 48.90M | 63.55% |
Dec 31, 2013 | 29.90M | 32.30% |
Dec 31, 2012 | 22.60M | 303.57% |
Dec 30, 2011 | 5.60M | -63.16% |
Dec 31, 2010 | 15.20M | -41.09% |
Dec 31, 2009 | 25.80M | 637.14% |
Dec 31, 2008 | 3.50M | -82.50% |
Dec 31, 2007 | 20.00M | 47.06% |
Dec 29, 2006 | 13.60M | -15.00% |
Dec 30, 2005 | 16.00M | -7.51% |
Dec 31, 2004 | 17.30M | -7.98% |
Dec 31, 2003 | 18.80M | 394.74% |
Dec 31, 2002 | 3.80M | -38.71% |
Dec 31, 2001 | 6.20M | -55.71% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 772.03B |
UnitedHealth Group | 386.16B |
Johnson & Johnson | 372.77B |
AbbVie | 319.07B |
Novo Nordisk | 276.96B |
Abbott Laboratories | 224.40B |
AstraZeneca | 215.41B |
Novartis AG | 210.89B |